MedPath

Fentanyl Citrate, Bupivacaine HCl

Fentanyl Citrate 2 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 125 mL Bag

Approved
Approval ID

2eb63a37-acd7-4b8a-a002-48e5060a703d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 12, 2015

Manufacturers
FDA

Cantrell Drug Company

DUNS: 035545763

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fentanyl Citrate, Bupivacaine HCl

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52533-080
Product Classification
G
Generic Name
Fentanyl Citrate, Bupivacaine HCl
Product Specifications
Route of AdministrationEPIDURAL
Effective DateJanuary 12, 2015
FDA Product Classification

INGREDIENTS (6)

HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: CNTM
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: CNTM
Fentanyl CitrateActive
Quantity: 2 ug in 1 mL
Code: MUN5LYG46H
Classification: ACTIM
WaterInactive
Code: 059QF0KO0R
Classification: IACT
BUPIVACAINE HYDROCHLORIDEActive
Quantity: 1.25 mg in 1 mL
Code: 7TQO7W3VT8
Classification: ACTIR
Sodium ChlorideInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fentanyl Citrate, Bupivacaine HCl - FDA Drug Approval Details